2026-2034年全球迷幻蘑菇市場規模、佔有率、趨勢和成長分析報告

預計到 2034 年，致幻蘑菇市場規模將從 2025 年的 18.7 億美元成長至 47.2 億美元，2026 年至 2034 年的複合年成長率為 10.81%。

隨著對致幻物質治療潛力的研究不斷深入，全球致幻蘑菇市場日益受到關注。含有裸蓋菇素等化合物的迷幻蘑菇正被研究用於治療憂鬱症、焦慮症和創傷後壓力症候群（PTSD）等精神疾病。人們對替代精神療法的興趣日益濃厚，也推動了該領域的研究和投資不斷增加。

多地監管政策的變化也影響市場發展。一些國家和地區正在重新審視迷幻物質用於醫學研究和治療的法律限制。這項變化促使製藥公司和研究機構探索基於裸蓋菇素治療方法的醫學應用。此外，臨床試驗也為迷幻劑輔助療法的潛在益處提供了新的見解。

展望未來，隨著科學研究不斷證實其治療應用價值，全球迷幻蘑菇市場預計將持續發展。各公司正在探索藥用級裸蓋菇素製劑以及針對精神疾病的受控治療方案。隨著人們對精神健康問題的認知不斷提高以及研究的深入，基於迷幻蘑菇的治療方法市場有望逐步擴大。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球迷幻蘑菇市場：依形態分類

• 市場分析、洞察與預測
• 按處理類型
• 乾粉
• 新鮮/完整形式

第5章：全球迷幻蘑菇市場：功能性

• 市場分析、洞察與預測
• 戒除成癮
• 緩解焦慮
• 憂鬱症的治療
• 用於休閒目的

第6章：全球迷幻蘑菇市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • MindMed
  • Atai Life Sciences
  • Compass Pathways
  • Field Trip Health
  • Cybin Inc
  • Revive Therapeutics
  • Numinus Wellness
  • Seelos Therapeutics
  • GH Research
  • Beckley Psytech

The Psychedelic Mushrooms Market size is expected to reach USD 4.72 Billion in 2034 from USD 1.87 Billion (2025) growing at a CAGR of 10.81% during 2026-2034.

The Global Psychedelic Mushrooms Market is gaining attention as research into the therapeutic potential of psychedelic substances continues to expand. Psychedelic mushrooms, which contain compounds such as psilocybin, are being studied for their potential use in treating mental health conditions including depression, anxiety, and post-traumatic stress disorder. Growing interest in alternative mental health therapies is contributing to increased research and investment in this field.

Regulatory changes in several regions are also influencing market development. Some countries and states are reconsidering legal restrictions on psychedelic substances for medical research and therapeutic use. This shift is encouraging pharmaceutical companies and research institutions to explore the medical applications of psilocybin-based treatments. Additionally, clinical trials are providing new insights into the potential benefits of psychedelic-assisted therapy.

Looking forward, the Global Psychedelic Mushrooms Market is expected to evolve as scientific research continues to validate therapeutic applications. Companies are exploring pharmaceutical-grade psilocybin formulations and controlled treatment programs for mental health disorders. As awareness of mental health challenges grows and research progresses, the market for psychedelic mushroom-based therapies may experience gradual expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Form

• Processed Form
• Dried Form
• Fresh/Whole Form

By Functionality

• De-Addiction
• Anxiety Relief
• Depression Treatment
• Recreational Use

COMPANIES PROFILED

• MindMed, Atai Life Sciences, Compass Pathways, Field Trip Health, Cybin Inc, Revive Therapeutics, Numinus Wellness, Seelos Therapeutics, GH Research, Beckley Psytech
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PSYCHEDELIC MUSHROOMS MARKET: BY FORM 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Form
• 4.2. Processed Form Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Dried Form Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Fresh/Whole Form Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PSYCHEDELIC MUSHROOMS MARKET: BY FUNCTIONALITY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Functionality
• 5.2. De-Addiction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Anxiety Relief Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Depression Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Recreational Use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PSYCHEDELIC MUSHROOMS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Form
  • 6.2.2 By Functionality
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Form
  • 6.3.2 By Functionality
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Form
  • 6.4.2 By Functionality
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Form
  • 6.5.2 By Functionality
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Form
  • 6.6.2 By Functionality
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PSYCHEDELIC MUSHROOMS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 MindMed
  • 8.2.2 Atai Life Sciences
  • 8.2.3 Compass Pathways
  • 8.2.4 Field Trip Health
  • 8.2.5 Cybin Inc
  • 8.2.6 Revive Therapeutics
  • 8.2.7 Numinus Wellness
  • 8.2.8 Seelos Therapeutics
  • 8.2.9 GH Research
  • 8.2.10 Beckley Psytech